The correct estimation of the VA origin as RVOT or LVOT results in reduced ablation duration reduced radiation exposure and decreased number of vascular access. In our study, we aimed to detect the predictive value of S-R difference in V1-V2 for differentiating the left from right ventricular outflow tract arrhythmias.
Aim:
The correct estimation of the VA origin as RVOT or LVOT results in reduced ablation duration reduced radiation exposure and decreased number of vascular access. In our study, we aimed to detect the predictive value of S-R difference in V1-V2 for differentiating the left from right ventricular outflow tract arrhythmias.
Methods:
We included 123 patients with symptomatic frequent premature ventricular outflow tract contractions who underwent successful catheter ablation (70 male, 53 female; mean age 46.2 ± 13.9 years, 61 RVOT, 62 LVOT origins). S-R difference in V1-V2 was calculated with this formula on the 12-lead surface ECG: (V1S + V2S) -(V1R + V2R). Conventional ablation was performed in 101 (82.1%) patients, CARTO electroanatomic mapping system was used in 22 (17.9%) patients.
Results: V1-2 SRd was found to be significantly lower for LVOT origins than RVOT origins (p < .001). The cutoff value of V1-2 SRd obtained by ROC curve analysis was 1.625 mV for prediction of RVOT origin (sensitivity: 95.1%, specificity: 85.5%, positive predictive value: 86.5%, negative predictive value: 94.5%). The area under the curve (AUC) was 0.929 (p < .001).
Conclusion: S-R difference in V1-V2 is a novel and simple electrocardiographic criterion for accurately differentiating RVOT from LVOT sites of ventricular arrhythmia origins. The use of this simple ECG measurement could improve the accuracy of OTVA localization, could be beneficial for decreasing ablation duration and radiation exposure. Further studies with larger patient population are needed to verify the results of this study.
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| INTRODUCTION
Outflow tract (OT) ventricular arrhythmias (OTVA) are usually considered a benign clinical condition. But cardiomyopathy induced or worsened by premature ventricular complexes (PVC) is a serious problem which can be reversed with ablation (Yarlagadda et al., 2005) .
Radiofrequency catheter ablation is accepted as safe and becoming a standard therapeutic strategy for idiopathic OTVAs (Ito et al., 2003; Kumagai et al., 2008; Takemoto et al., 2005) . There are complex three dimensional anatomic relationships between the two outflow tract regions. So, it is challenging to recognize the origin of the OTVAs. Different electrocardiographic (ECG) algorithms have been proposed for differentiation of left ventricular (LV) outflow tract (LVOT) and right ventricular (RV) outflow tract RVOT origin of OTVAs (Bala et al., 2010; Ouyang et al., 2002; Yamada et al., 2008; Yang et al., 2007; Zhang et al., 2009) . Their accuracy and usefulness remain limited especially when the transition in the precordial leads occurs in V3 (Yoshida et al., 2014) .
The prediction of RVOT or LVOT origin based on ECG is of great value. Because the correct estimation of the VA origin as RVOT or LVOT results in reduced ablation duration, reduced radiation exposure, decreased number of vascular access. This information is also important for patient counseling, physician procedural planning, and logistics.
In our study, we aimed to detect the predictive value of S-R difference in V1-V2 (V1-2 SRd) for differentiating the left from right ventricular outflow tract arrhythmias.
| METHODS

| Study protocol and study population
We included 123 patients with symptomatic frequent premature ven- 
| Electrocardiographic assessment
The surface 12 lead ECGs were recorded during sinus rhythm and during the PVCs at 25 mm/s speed with chest and limb leads placed in a standard position in all patients. Special attention was paid to the correct positioning of V1 and V2. QRS duration was measured in the lead with widest QRS complex on the 12-lead surface ECG (Zhang et al., 2009 ). S-R difference in V1-V2 was calculated with this formula on the 12-lead surface ECG: V1-2 SRd (mV): (V1S amplitude + V2S amplitude) -(V1R amplitude + V2R amplitude) (Figure 1 ). All measurements were performed by two electrophysiologists who were blinded to the final diagnosis and the site of origin in order to eliminate the interobserver variability and bias.
| Ablation protocol
All antiarrhythmic medications were discontinued at least five half lives before the ablation. We performed the ablation procedure with 
| Statistical analyses
Statistical analyses were conducted using SPSS, version 14.0, (SPSS Inc. Chicago, IL, USA). Data are expressed as mean ± SD for continuous variables and percentage for categorical variables. The ShapiroWilk test was used to test normality and a p value >.05 was defined as normally distributed data. Continuous variables that showed normal distribution were compared using the Student t test and ANOVA, whereas the Mann-Whitney U test and Kruskal-Wallis test were used for nonnormally distributed samples. Associations of the categorical variables between groups were tested using the chi-square test. Statistical significance was defined as a p value <.05 for all comparisons. Pearson's and Spearman's correlation were used to examine the relationship between continuous variables. ROC analysis was made to determine cutoff value of V1-2 SRd for differentiating the left from right ventricular outflow tract arrhythmias.
| RESULTS
| Comparison of baseline characteristics
A comparison of the baseline characteristics is shown in Table 1 .
Successful ablation was accomplished in all patients. OTVA was localized in the LVOT in 62 patients (50.4%), and in the RVOT in 61 patients (49.6%). Among patients with LVOT VA, in 43 patients the successful ablation site was localized in the aortic cusps, in 19 patients the successful ablation site was localized in subvalvular LVOT. Among patients with RVOT VA, in 60 patients the successful ablation site was localized in subvalvular RVOT, in one patient the successful ablation site was localized in the pulmonary artery. All clinical and demographic characteristics, laboratory, echocardiographic parameters were similar in the two groups (p > .05, for all). Patients with LVOT VA were significantly older (p < .05) as compared with RVOT VA patients. V1-2 SRd was found to be significantly lower in LVOT origins than RVOT origins (p < .001).
| ROC curve analysis to determine predictive value of V1-2 SRd for differentiating the left from right ventricular outflow tract arrhythmias
The cutoff value of V1-2 SRd obtained by ROC curve analysis was 
| DISCUSSION
We developed a novel ECG criterion, S-R difference in V1-V2, for differentiating the LVOT and RVOT origin by using 12 lead surface ECG measurements. To our knowledge, this is the first study that demonstrates the predictive value of S-R difference in V1-V2 for differentiating the left from right ventricular outflow tract arrhythmias. The main finding of the present study is that: [1] If we take the cutoff value as 1.625 mV, V1-2 SRd was found to predict RVOT origin with 95.1% sensitivity and 85.5% specificity.
Outflow tract ventricular arrhythmias are considered idiopathic and benign VA, not associated with structural heart disease and cardiovascular risk factors. They are frequently observed in young women.
OTVAs are known to mostly originate from RVOT in the literature (Buxton et al., 1983) . However, contrary to the previously accepted Prior ablation history (n,%) 5 (8.2) 2 (3.2) .273
TICMP, n (%) 4 (6.6) 4 (6.5) .981
Patients treated with CARTO (n,%) 7 (11.5) 15 (24.2) .066
Bold values indicate statistical significance. V1-2 SRd, S-R difference in V1-V2, LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract; TICMP, tachycardia-induced cardiomyopathy.
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